KLIKJARO
TIRZ-15
Prefilled Klik-Pen
Tirzepatide is a dual GIP/GLP-1 receptor agonist researched for metabolic regulation, delivered in a once-weekly prefilled Klik-pen.
Scientific Specifications
Modified dual GIP/GLP-1 agonistProduct Details
KLIKJARO contains tirzepatide, the first dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. Each pen contains 60mg/2.4ml (4 doses of 15mg). Its 39-amino acid sequence is based on the GIP sequence with modifications enabling GLP-1 receptor co-activation. A C20 fatty diacid moiety enables albumin binding for once-weekly dosing. Research demonstrates superior efficacy in glycemic control and weight reduction compared to selective GLP-1 agonists.
Related Products
All products are sold strictly for research and laboratory use only. Not for human consumption. By purchasing, you agree to use these products only for legitimate research purposes.